| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.10▼ | 10.10▼ | 10.10▼ | 10.15▼ | 10.14▲ |
| MA10 | 10.09▲ | 10.09▲ | 10.09▲ | 10.15▼ | 10.12▲ |
| MA20 | 10.05▲ | 10.05▲ | 10.05▲ | 10.14▲ | 10.08▲ |
| MA50 | N/A | N/A | N/A | 10.11▲ | N/A |
| MA100 | N/A | N/A | N/A | 10.07▲ | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | 0.000▼ | N/A |
| RSI | 72.065▲ | 72.648▲ | 72.831▲ | 61.910▲ | 70.181▲ |
| STOCH | 93.333▲ | 93.333▲ | 93.333▲ | 66.667 | 84.821▲ |
| WILL %R | -28.571 | -28.571 | -28.571 | -40.000 | -16.667▲ |
| CCI | 77.333 | 76.543 | 76.543 | 36.061 | 127.726▲ |
|
Monday, September 14, 2020 04:00 AM
CAMBRIDGE, Mass., Sept. 14, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/08/26 | 10.15 | 10.15 | 10.15 | 10.15 | 0 |
| 06/08/26 | 10.15 | 10.15 | 10.15 | 10.15 | 0 |
| 05/08/26 | 10.17 | 10.17 | 10.15 | 10.15 | 2,211 |
| 31/07/26 | 10.16 | 10.17 | 10.16 | 10.17 | 10,914 |
| 30/07/26 | 10.15 | 10.15 | 10.15 | 10.15 | 3,282 |
| 29/07/26 | 10.15 | 10.15 | 10.14 | 10.15 | 47,526 |
| 28/07/26 | 10.15 | 10.15 | 10.15 | 10.15 | 96,475 |
| 27/07/26 | 10.14 | 10.14 | 10.14 | 10.14 | 18,006 |
| 24/07/26 | 10.15 | 10.15 | 10.15 | 10.15 | 2,405 |
| 23/07/26 | 10.14 | 10.14 | 10.14 | 10.14 | 11,111 |
|
|
||||
|
|
||||
|
|